HalioDx

HalioDx

HalioDx

HalioDx is an immunooncology diagnostic company providing oncologists with firstinclass Immunebased diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immunooncology and combination therapies.
Type
B2b
Founded
2015
Raised
$22.3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
€18,500,000
Venture capital (Series B) - 2018
Quest for Growth MI Care BNP Paribas Développement +6
Team Size
50+
Employees
Location
Headquarters
€18,500,000 Venture capital (Series B)
FinSMEs

HalioDx Closes €18.5M Series B Financing

Funding Health